Item 8.01 Other Events
On March 26, 2021 Regen Biopharma, Inc. ( "Regen") filed a CERTIFICATE OF
DESIGNATION ("Certificate of Designations") with the Nevada Secretary of State
setting forth the preferences rights and limitations of a newly authorized
series of preferred stock designated and known as Nonconvertible Series NC
Preferred Stock (hereinafter referred to as "Series NC Preferred Stock").
The Board of Directors of Regen have authorized 20,000 shares of the Series NC
Preferred Stock, par value $0.0001. With respect to each matter submitted to a
vote of stockholders of Regen, each holder of Series NC Preferred Stock shall be
entitled to cast that number of votes which is equivalent to the number of
shares of Series NC Preferred Stock owned by such holder times 500,000. Except
as otherwise required by law holders of Common Stock, other series of Preferred
issued by Regen, and Series NC Preferred Stock shall vote as a single class on
all matters submitted to the stockholders.
The holders of Series NC Preferred Stock shall be entitled receive dividends,
when, as and if declared by the Board of Directors in accordance with Nevada
Law, in its discretion, from funds legally available therefore
On any voluntary or involuntary liquidation, dissolution or winding up of Regen,
the holders of the Series NC Preferred Stock shall receive, out of assets
legally available for distribution to Regen's stockholders, a ratable share in
the assets of Regen.
Item 9.01 Exhibits
Exhibit No. Description of Exhibit
3(i) Text of Certificate of Designations
2
© Edgar Online, source Glimpses